Cognitive Behavior Therapy for Anxiety in Parkinson's Disease: Outcomes for Patients and Caregivers

被引:43
作者
Dissanayaka, Nadeeka N. W. [1 ,2 ]
Pye, Deidre [1 ]
Mitchell, Leander K. [1 ]
Byrne, Gerard J. [1 ,2 ]
O'Sullivan, John D. [1 ,2 ]
Marsh, Rodney [1 ,2 ]
Pachana, Nancy A. [1 ]
机构
[1] Univ Queensland, Brisbane, Qld, Australia
[2] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
关键词
Anxiety; caregivers; cognitive behavioral therapy; Parkinson's disease; RATING-SCALE; CONTROLLED TRIAL; DEPRESSION; RELIABILITY; PREVALENCE; VALIDATION; DISORDERS; INTERVIEW; PREDICTORS; INVENTORY;
D O I
10.1080/07317115.2016.1240131
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: Anxiety negatively impacts the quality of life of Parkinson's disease (PD) patients and caregivers. Despite high prevalence, there is a paucity of trials investigating effective treatments for anxiety in PD. This uncontrolled study investigated the use of a manualized and tailored Cognitive Behavior Therapy (CBT) for anxiety in PD.Methods: Participants completed 6 weekly CBT sessions. Pre-, post- and follow-up (3 and 6months) assessments were made. Change in outcomes were analysed using t-tests and Reliability Change Index. Of 17 PD patients who agreed to CBT, 12 completed the intervention.Results: This study showed a significant reduction in Hamilton Anxiety Rating Scale scores in PD immediately post CBT (t(11)=3.59, p<.01), maintained at 3-month (t(8)=2.83, p=.02) and 6-month (t(7)=2.07, p=.04) follow-up. A reduction in caregiver burden (t(11)=2.68, p=.03) was observed post intervention. Improvements in motor disability (t(11)=2.41, p=.04) and cognitive scores (t(11)=-2.92, p=.01) were also observed post intervention and at follow-up.Conclusions: Tailored CBT can be used to treat anxiety in PD.Clinical Implications: This study provides preliminary evidence suggesting that tailored CBT reduces anxiety in PD with persisting benefits, and lowers caregiver burden.
引用
收藏
页码:159 / 171
页数:13
相关论文
共 58 条
[11]   The Zarit Burden Interview:: A new short version and screening version [J].
Bédard, M ;
Molloy, DW ;
Squire, L ;
Dubois, S ;
Lever, JA ;
O'Donnell, M .
GERONTOLOGIST, 2001, 41 (05) :652-657
[12]  
Byrne G, 2005, INT PSYCHOGERIATR, V17, P136
[13]  
Casacchia M, 1975, Riv Neurol, V45, P326
[14]   Anxiety in Parkinson's disease: identification and management [J].
Chen, Jack J. ;
Marsh, Laura .
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2014, 7 (01) :52-59
[15]   Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson's Disease [J].
Connolly, Barbara ;
Fox, Susan H. .
NEUROTHERAPEUTICS, 2014, 11 (01) :78-91
[16]   Benzodiazepines and risk of hip fractures in older people - A review of the evidence [J].
Cumming, RG ;
Le Couteur, DG .
CNS DRUGS, 2003, 17 (11) :825-837
[17]   The Clinical Spectrum of Anxiety in Parkinson's Disease [J].
Dissanayaka, Nadeeka N. N. W. ;
White, Elizabeth ;
O'Sullivan, John D. ;
Marsh, Rodney ;
Pachana, Nancy A. ;
Byrne, Gerard J. .
MOVEMENT DISORDERS, 2014, 29 (08) :967-975
[18]   Validity of Hamilton depression inventory in Parkinson's disease [J].
Dissanayaka, Nadeeka N. W. ;
Sellbach, Anna ;
Matheson, Sally ;
Marsh, Rodney ;
Silburn, Peter A. ;
O'Sullivan, John D. ;
Byrne, Gerard J. ;
Mellick, George D. .
MOVEMENT DISORDERS, 2007, 22 (03) :399-403
[19]   Disease-specific anxiety symptomatology in Parkinson's disease [J].
Dissanayaka, Nadeeka N. W. ;
O'Sullivan, John D. ;
Pachana, Nancy A. ;
Marsh, Rodney ;
Silburn, Peter A. ;
White, Elizabeth X. ;
Torbey, Elizabeth ;
Mellick, George D. ;
Copland, David A. ;
Byrne, Gerard J. .
INTERNATIONAL PSYCHOGERIATRICS, 2016, 28 (07) :1153-1163
[20]   Characteristics and Treatment of Anxiety Disorders in Parkinson's Disease [J].
Dissanayaka, Nadeeka N. W. ;
White, Elizabeth ;
O'Sullivan, John D. ;
Marsh, Rodney ;
Silburn, Peter A. ;
Copland, David A. ;
Mellick, George D. ;
Byrne, Gerard J. .
MOVEMENT DISORDERS CLINICAL PRACTICE, 2015, 2 (02) :155-162